A detailed history of Wr Wealth Planners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wr Wealth Planners, LLC holds 1,224 shares of GILD stock, worth $102,681. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,224
Previous 1,140 7.37%
Holding current value
$102,681
Previous $83,000 -0.0%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$63.15 - $72.88 $5,304 - $6,121
84 Added 7.37%
1,224 $83,000
Q1 2024

Jul 31, 2024

BUY
$71.58 - $87.29 $81,601 - $99,510
1,140 New
1,140 $83,000
Q3 2023

Aug 01, 2024

SELL
$73.94 - $80.67 $13,826 - $15,085
-187 Reduced 15.73%
1,002 $75.1 Million
Q2 2023

Aug 01, 2024

SELL
$76.01 - $86.7 $2,660 - $3,034
-35 Reduced 2.86%
1,189 $91.6 Million
Q1 2023

Aug 01, 2024

SELL
$77.31 - $88.08 $77 - $88
-1 Reduced 0.08%
1,223 $101 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $105B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Wr Wealth Planners, LLC Portfolio

Follow Wr Wealth Planners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wr Wealth Planners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wr Wealth Planners, LLC with notifications on news.